Learn more about what PurpleLab can do for Clinical Trials Life Sciences Clinical trials are essential for drug development, yet they frequently face delays due to ineffective site selection, leading to protocol violations, compromised data quality, and soaring costs. In fact, 90% of trials fail to meet their timelines, often due to inadequate staffing and…

As the pharmaceutical and healthcare media industries face unprecedented change, the Preparing for 2025 roundtable convened leading experts to chart a path forward. Against a backdrop of rising patient expectations, accelerating technological advancements, and increasing regulatory pressures, this collaborative forum sought to address critical challenges while uncovering collective alignment for sustainable success.

PurpleLab® provides a real-world data [lab], accelerating the discovery and adoption of healthcare innovations. View where PurpleLab insights have been leveraged.  IT DIGEST PurpleLab and Payerset Partner to Enhance Healthcare Decisions Read Now 2/14/2025 AXIOS Use of diabetes and anti-obesity drugs surged nationwide 2023-24 Read Now 1/3/2025 Broad-casting Cable VideoAmp Dials Up Outcome Measurement Read…

PurpleLab® took part in HLTH 24’s Payer Insights Session on October 20th, 2024. Led by Med City New’s Arundhati Pramar, we were joined on stage by Humana’s Pankhuri Sharma and Managed Care Resource Alliance’s Darren E. Wethers for an insightful discussion on how payers can leverage claims data insights to link reimbursements and preventive care. We invite…

We are in the middle of an ongoing data-driven revolution in the pharmaceutical industry. Data and analytics are reshaping how companies approach sales and marketing strategies – and customer experience.

The value of real-world data (RWD) and real-world evidence (RWE) for pharmaceutical companies goes far beyond clinical and drug development applications, such as clinical trial feasibility studies, manufacturing, health economic and outcomes research and medical affairs. These datasets are also recognized as critical tools for shaping effective marketing and commercial strategies. The importance of real-world…

PurpleLab®, a leading healthcare analytics company with one of the largest medical and pharmaceutical claims databases in the US, is pleased to announce its membership in the Network Advertising Initiative (NAI), the leading self-regulatory organization dedicated to responsible data collection and use in digital advertising. In joining the NAI, PurpleLab strengthens its commitment to maintaining…

Pharmaceutical advertisers and companies must develop marketing strategies that are multilayered as third-party cookies become a liability. Audience-based solutions remain part of this, but marketers should collaborate with their agency and ad tech partners to integrate real-world data in the pre-campaign planning, campaign launch and optimization phases. Discuss differences in content consumption based on health conditions, compare web behavior vs. TV viewing habits and how healthcare-focused supply analysis can feed into SPO applications.

More than a year has passed since Humira biosimilars were launched in the US, and with these, several other biosimilar drug approvals that either directly compete with Humira or are indicated for other rare immunologic conditions, macular degeneration, and oncology and hematological disease.  Ongoing industry surveillance of biosimilars and the   Source: “Biosimilars are becoming more widely available,…